Deciphering the mystery of thalidomide teratogenicity

Congenital Anomalies
T Ito, Hiroshi Handa

Abstract

Thalidomide was originally developed in 1954 as a sedative that was commonly used to ameliorate morning sickness. However, thalidomide exposure during the first trimester of pregnancy caused multiple birth defects (e.g. phocomelia and amelia), affecting ≈ 10,000 children worldwide in the late 1950s and early 1960s. Thalidomide is now recognized as a clinically effective, albeit strictly restricted, drug for the treatment of leprosy and multiple myeloma. Investigators have studied thalidomide teratogenicity for half a century, proposing over 30 hypotheses to account for its actions. Among these, the anti-angiogenesis and oxidative stress models have gained widespread support. Nonetheless, the precise molecular mechanisms and direct targets of thalidomide have not heretofore been elucidated. We developed ferrite-glycidyl methacrylate beads that enable magnetic separation and efficient purification of ligand-binding molecules; the beads were recently employed to identify cereblon as a primary target of thalidomide. Cereblon forms an E3 ubiquitin ligase complex with DDB1, Cul4A, and Roc1, which is important for the expression of fibroblast growth factor 8, an essential regulator of limb development. Expression of a drug binding-def...Continue Reading

References

Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·R J D'AmatoJ Folkman
Dec 1, 1996·Teratology·E E CastillaL Schüler
Nov 24, 1999·The New England Journal of Medicine·S SinghalB Barlogie
Feb 8, 2000·Teratology·T D Stephens, B J Fillmore
Aug 10, 2000·Nature Biotechnology·N ShimizuH Handa
Dec 2, 2000·Nature Genetics·A M Moon, M R Capecchi
Dec 2, 2000·Nature Genetics·M LewandoskiG R Martin
Sep 21, 2002·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Jason M HansenCraig Harris
Sep 12, 2003·DNA Repair·Birgitte Ø Wittschieben, Richard D Wood
Dec 6, 1962·The New England Journal of Medicine·G W MELLIN, M KATZENSTEIN
May 1, 1965·Clinical Pharmacology and Therapeutics·J SHESKIN
Jan 10, 2004·Antioxidants & Redox Signaling·Jason M Hansen, Craig Harris
Jan 28, 2004·Cell·Cecile M Pickart
Apr 2, 2004·Nature Reviews. Cancer·J Blake BartlettAngus G Dalgleish
Jun 3, 2004·Lancet·Michael E FranksWilliam D Figg
Feb 3, 2005·Nature Reviews. Molecular Cell Biology·Matthew D Petroski, Raymond J Deshaies
Feb 7, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jürgen KnoblochUlrich Rüther
Feb 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Yong CangStephen P Goff
Mar 21, 2007·The International Journal of Biochemistry & Cell Biology·Magda Melchert, Alan List
Mar 30, 2007·Nature·Fumiaki OhtakeShigeaki Kato
Jun 1, 2007·Development·Sangeeta Pajni-UnderwoodMark Lewandoski
Jun 26, 2007·Molecular Cell·Jennifer Lee, Pengbo Zhou
Aug 7, 2007·Birth Defects Research. Part A, Clinical and Molecular Teratology·Lavinia Schuler-FacciniEduardo Enrique Castilla
Mar 4, 2008·Colloids and Surfaces. B, Biointerfaces·Kosuke NishioHiroshi Handa
Jan 27, 2009·FEBS Letters·Bettina Hohberger, Ralf Enz
Feb 27, 2009·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Satoshi SakamotoHiroshi Handa
May 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·Christina TherapontosNeil Vargesson
Nov 19, 2009·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Neil Vargesson
Mar 13, 2010·Science·Takumi ItoHiroshi Handa
Nov 30, 2010·Cell·Philip Cohen, Marianna Tcherpakov
Dec 4, 2010·Blood Reviews·Faith Davies, Rachid Baz
Dec 15, 2010·Nature Reviews. Drug Discovery·Lynn BedfordJames E Brownell

❮ Previous
Next ❯

Citations

Aug 25, 2012·Advances in Hematology·Roberta MartinianiAnna Marina Liberati
Apr 11, 2014·Trends in Pharmacological Sciences·Jennie R Lill, Ingrid E Wertz
Sep 25, 2015·Clinical Research and Regulatory Affairs·Kristin N GrimsrudNicole L Mihalopoulos
Oct 24, 2012·Reproductive Toxicology·Jason M Hansen, Craig Harris
Sep 20, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Erica L L WarkusYusuke Marikawa
Nov 15, 2014·Environmental Science and Pollution Research International·Thomas BraunbeckRuben Strecker
Nov 11, 2016·Journal of Gastroenterology·Heyson Chi-Hey Chan, Siew Chien Ng
Dec 18, 2016·Indian Journal of Pediatrics·Rosalba Sevilla-MontoyaPatricia Grether
Jan 1, 2014·Acta Biochimica Et Biophysica Sinica·Xiubao ChangA Keith Stewart
May 24, 2018·Cardiovascular & Hematological Disorders Drug Targets·Ota Fuchs
Mar 29, 2014·Congenital Anomalies·Masakazu HashimotoNaoto Ueno
Apr 22, 2020·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Shujie LiuJunichi Tasaki
Mar 15, 2020·International Journal of Environmental Research and Public Health·Elena Rocca, Rani Lill Anjum
Feb 3, 2020·Cellular and Molecular Life Sciences : CMLS·Chao-Tao TangZhi-Zheng Ge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.